Tackling obesity during the COVID-19 pandemic

doi:10.1002/dmrr.3393

. 2021 Mar;37(3):e3393.

doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.

Tackling obesity during the COVID-19 pandemic

Amit Akirov^{1

2}, Avivit Cahn³, Stefano Del Prato⁴, Philip Home⁵, Luc Van Gaal⁶, Juliana Chan^{7

8

9}, Guang Ning¹⁰, Itamar Raz³

Affiliations

¹ Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel.
² Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Clinical & Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy.
⁵ Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
⁶ Department of Endocrinology & Metabolism, Antwerp University Hospital, Edegem-Antwerp, Belgium.
⁷ Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁸ Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁹ Li Ka Shing Institute of Health Science, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
¹⁰ Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

PMID: 32797666
PMCID: PMC7435354
DOI: 10.1002/dmrr.3393

Tackling obesity during the COVID-19 pandemic

Amit Akirov et al. Diabetes Metab Res Rev. 2021 Mar.

. 2021 Mar;37(3):e3393.

doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.

Authors

Amit Akirov^{1

2}, Avivit Cahn³, Stefano Del Prato⁴, Philip Home⁵, Luc Van Gaal⁶, Juliana Chan^{7

8

9}, Guang Ning¹⁰, Itamar Raz³

Affiliations

¹ Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel.
² Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Clinical & Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy.
⁵ Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
⁶ Department of Endocrinology & Metabolism, Antwerp University Hospital, Edegem-Antwerp, Belgium.
⁷ Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁸ Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
⁹ Li Ka Shing Institute of Health Science, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
¹⁰ Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

PMID: 32797666
PMCID: PMC7435354
DOI: 10.1002/dmrr.3393

No abstract available

Keywords: COVID-19; diabetes; obesity; pre-diabetes.

PubMed Disclaimer

Conflict of interest statement

All authors have no conflict of interest relevant to this paper to declare.

This is a review and not a study involving human or animal studies, therefore ethics approval was not required.

Amit Akirov and Avivit Cahn drafted the manuscript. All authors reviewed the manuscript, provided comments and expanded discussion and all authors approve the final submitted version.

Cited by

The Challenges and Strategies towards Healthy Eating during COVID-19 Home Confinement Period among Working Adults with BMI ≥ 25 kg/m² Enrolled in a Weight Loss Program: Qualitative Findings.
Abdul Basir SM, Abdul Manaf Z, Mohd Noor N, Mat Ludin AF, Shahar S, Abdul Manaf MR. Abdul Basir SM, et al. Int J Environ Res Public Health. 2022 May 30;19(11):6656. doi: 10.3390/ijerph19116656. Int J Environ Res Public Health. 2022. PMID: 35682248 Free PMC article.

References

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China. JAMA. 2020;323(13):1239. 10.1001/jama.2020.2648. - DOI - PubMed
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062. - PMC - PubMed
1. Zhang F, Xiong Y, Wei Y, et al. Obesity predisposes to the risk of higher mortality in young COVID‐19 patients. J Med Virol. 2020. 10.1002/jmv.26039. - DOI - PMC - PubMed
1. Gao F, Zheng KI, Wang X, et al. Obesity is a risk factor for greater COVID‐19 severity. Diabetes Care. 2020;43:e72‐e74. - PubMed
1. Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID‐19 in France. Lancet Diabetes Endocrinol. 2020;8:562‐564. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China. JAMA. 2020;323(13):1239. 10.1001/jama.2020.2648. - DOI - PubMed

[2] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China. JAMA. 2020;323(13):1239. 10.1001/jama.2020.2648. - DOI - PubMed

[3] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062. - PMC - PubMed

[4] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062. - PMC - PubMed

[5] Zhang F, Xiong Y, Wei Y, et al. Obesity predisposes to the risk of higher mortality in young COVID‐19 patients. J Med Virol. 2020. 10.1002/jmv.26039. - DOI - PMC - PubMed

[6] Zhang F, Xiong Y, Wei Y, et al. Obesity predisposes to the risk of higher mortality in young COVID‐19 patients. J Med Virol. 2020. 10.1002/jmv.26039. - DOI - PMC - PubMed

[7] Gao F, Zheng KI, Wang X, et al. Obesity is a risk factor for greater COVID‐19 severity. Diabetes Care. 2020;43:e72‐e74. - PubMed

[8] Gao F, Zheng KI, Wang X, et al. Obesity is a risk factor for greater COVID‐19 severity. Diabetes Care. 2020;43:e72‐e74. - PubMed

[9] Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID‐19 in France. Lancet Diabetes Endocrinol. 2020;8:562‐564. - PMC - PubMed

[10] Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID‐19 in France. Lancet Diabetes Endocrinol. 2020;8:562‐564. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Tackling obesity during the COVID-19 pandemic

Affiliations

Tackling obesity during the COVID-19 pandemic

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical